EBSCO Logo
Connecting you to content on EBSCOhost
Results
Title

Interleukin 25 (IL-25) expression in cholangiocarcinoma.

Authors

Kaewsarabhumi, Supakit; Proungvitaya, Tanakorn; Limpaiboon, Temduang; Tippayawat, Patcharaporn; Tummanatsakun, Doungdean; Titapun, Attapol; Sa-Ngaimwibool, Prakasit; Proungvitaya, Siriporn

Abstract

Various cytokines are involved in carcinogenesis and tumor progression. Some tumor cells produce cytokines by themselves. Using secretome analysis, a high expression of APEX-1 was found in cholangiocarcinoma (CCA) cell lines. During this secretome analysis, it was found that CCA cell lines overexpressed some cytokines and related molecules, including interleukin 25 (IL-25). In the present study, we first performed precise secretome analysis on cytokines and related molecules in CCA cell lines and identified that IL-25 was overexpressed in CCA cell lines. Then, using immunohistochemical methods, we investigated the expression of IL-25 in the cancer tissues from 20 CCA patients in Northeast Thailand. Correlation between IL-25 expression levels and patients' clinical parameters were analyzed. The results showed that IL-25 expression was significantly (P<0.0001) higher in cancerous tissues than in the normal bile ducts and in the adjacent tissues. Overexpression of IL-25 protein in CCA tissue was confirmed using western blot analysis. Moreover, IL-25 expression in cancerous tissues was significantly (P<0.0015) higher in CCA patients with metastasis than in CCA patients without metastasis. Survival analysis revealed that a high expression of IL-25 was correlated with shorter survival time of CCA patients (P=0.0260). Aberrant expression of IL-25 in CCA tissue was associated with tumor metastasis and poor prognosis, suggesting that IL-25 is a potential prognostic biomarker. Biological roles of IL-25 in CCA genesis and progression should be explored in future.

Subjects

WESTERN immunoblotting; SURVIVAL analysis (Biometry); BILE ducts; CANCER invasiveness; CELL lines; HUMAN carcinogenesis

Publication

Molecular & Clinical Oncology, 2020, Vol 13, Issue 6, pN.PAG

ISSN

2049-9450

Publication type

Academic Journal

DOI

10.3892/mco.2020.2154

EBSCO Connect | Privacy policy | Terms of use | Copyright | Manage my cookies
Journals | Subjects | Sitemap
© 2025 EBSCO Industries, Inc. All rights reserved